Ted Buchan & CO Bristol Myers Squibb CO Transaction History
Ted Buchan & CO
- $211 Billion
- Q3 2024
A detailed history of Ted Buchan & CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ted Buchan & CO holds 22,257 shares of BMY stock, worth $1.33 Million. This represents 0.55% of its overall portfolio holdings.
Number of Shares
22,257Holding current value
$1.33 Million% of portfolio
0.55%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,477Shares Held
1.51BCall Options Held
29.6MPut Options Held
32.1M-
Vanguard Group Inc Valley Forge, PA187MShares$11.2 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.49 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$5.47 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.66 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.65 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $127B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...